HPGDS and renal cell adenocarcinoma: Because the differential expression of GSTs has been found to markedly influence the anticarcinogenic potential of tissues since it was first suggested as a potential marker for cancer susceptibility in 1986 [11], GSTs are currently being investigated as risk biomarkers for various cancers, including RCC [12]–[15].